Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPRENORPHINE Cause Mobility decreased? 489 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 489 reports of Mobility decreased have been filed in association with BUPRENORPHINE (Buprenorphine and Naloxone). This represents 0.6% of all adverse event reports for BUPRENORPHINE.

489
Reports of Mobility decreased with BUPRENORPHINE
0.6%
of all BUPRENORPHINE reports
419
Deaths
398
Hospitalizations

How Dangerous Is Mobility decreased From BUPRENORPHINE?

Of the 489 reports, 419 (85.7%) resulted in death, 398 (81.4%) required hospitalization, and 383 (78.3%) were considered life-threatening.

Is Mobility decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPRENORPHINE. However, 489 reports have been filed with the FAERS database.

What Other Side Effects Does BUPRENORPHINE Cause?

Drug dependence (16,730) Overdose (13,977) Death (13,604) Toxicity to various agents (10,906) Pain (8,219) Drug withdrawal syndrome (7,149) Emotional distress (6,159) Drug abuse (4,344) Drug ineffective (4,261) Dependence (3,184)

What Other Drugs Cause Mobility decreased?

ADALIMUMAB (8,829) ETANERCEPT (8,321) METHOTREXATE (5,936) ABATACEPT (4,519) TOCILIZUMAB (4,403) LEFLUNOMIDE (4,354) HYDROXYCHLOROQUINE (4,105) RITUXIMAB (4,067) INFLIXIMAB (3,784) TOFACITINIB (3,734)

Which BUPRENORPHINE Alternatives Have Lower Mobility decreased Risk?

BUPRENORPHINE vs BUPRENORPHINE\NALOXONE BUPRENORPHINE vs BUPROPION BUPRENORPHINE vs BUPROPION HYDROBROMIDE BUPRENORPHINE vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE BUPRENORPHINE vs BUPROPION\NALTREXONE

Related Pages

BUPRENORPHINE Full Profile All Mobility decreased Reports All Drugs Causing Mobility decreased BUPRENORPHINE Demographics